Citigroup Inc Recursion Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 190,752 shares of RXRX stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190,752

Previous 103,610 84.11%

Holding current value

$1.38 Million

Previous $777,000 61.78%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.92 - $8.6 $515,880 - $749,421	87,142 Added 84.11%	190,752 $1.26 Million
Q2 2024 Aug 12, 2024	SELL	$7.35 - $10.05 $5.13 Million - $7.01 Million	-697,577 Reduced 87.07%	103,610 $777,000
Q1 2024 May 10, 2024	BUY	$9.13 - $15.52 $3.62 Million - $6.15 Million	396,334 Added 97.9%	801,187 $7.99 Million
Q4 2023 Feb 09, 2024	SELL	$5.09 - $10.79 $334,204 - $708,460	-65,659 Reduced 13.95%	404,853 $3.99 Million
Q3 2023 Nov 09, 2023	BUY	$6.59 - $15.86 $1.93 Million - $4.65 Million	293,174 Added 165.32%	470,512 $3.6 Million
Q2 2023 Aug 10, 2023	SELL	$4.56 - $9.94 $2.33 Million - $5.08 Million	-510,887 Reduced 74.23%	177,338 $1.32 Million
Q1 2023 May 11, 2023	BUY	$6.42 - $9.64 $2.92 Million - $4.39 Million	455,398 Added 195.6%	688,225 $4.59 Million
Q4 2022 Feb 09, 2023	BUY	$7.16 - $12.7 $510,271 - $905,090	71,267 Added 44.11%	232,827 $1.8 Million
Q3 2022 Nov 10, 2022	BUY	$7.83 - $13.6 $1.17 Million - $2.03 Million	149,260 Added 1213.5%	161,560 $1.72 Million
Q2 2022 Aug 10, 2022	SELL	$5.04 - $9.26 $13,098 - $24,066	-2,599 Reduced 17.44%	12,300 $100,000
Q1 2022 May 12, 2022	SELL	$6.16 - $18.03 $1.41 Million - $4.14 Million	-229,458 Reduced 93.9%	14,899 $106,000
Q4 2021 Feb 10, 2022	BUY	$16.14 - $21.86 $3.21 Million - $4.35 Million	199,063 Added 439.49%	244,357 $4.19 Million
Q3 2021 Nov 10, 2021	BUY	$19.03 - $41.33 $861,944 - $1.87 Million	45,294 New	45,294 $1.04 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account